A clinical case of peripheral T-cell lymphoma in a patient with HIV infection
https://doi.org/10.22625/2072-6732-2025-17-4-159-163
Abstract
Lymphoma is the most common malignant disease in patients with HIV infection in the advanced stages of the disease. The incidence of T-cell lymphomas in the presence of HIV infection is 12–15%, and, unlike B-cell lymphomas, they are usually associated with a worse treatment outcome. This paper presents a case of cutaneous T-cell lymphoma (mycosis fungoides) in an HIV-infected man. Lymphoproliferative diseases can be hidden under the mask of diseases such as atopic dermatitis, psoriasis, parapsoriasis, eczema, mycosis of the skin, which are difficult to respond to the recommended type of therapy.
In order to prevent misdiagnosis in such cases, it is necessary to carry out a histological examination of the skin flap, on the basis of which it is possible to establish the exact nature of the lesion.
About the Authors
A. S. ShelomovRussian Federation
Saint-Petersburg
Ya. G. Bejanyan
Russian Federation
Saint-Petersburg
E. V. Stepanova
Russian Federation
Saint-Petersburg
S. S. Burdaeva
Russian Federation
Saint-Petersburg
References
1. Katsura Y, Ota I, Yoshida C, Ohtani H, Komeno T. HIVassociated peripheral T-cell lymphoma with a cytotoxic phenotype. Intern Med. 2014;53(18):2127-31. doi: 10.2169/internalmedicine.53.1990. Epub 2014 Sep 15. PMID: 25224201.
2. Wang M, Kibbi N, Ring N, Siddon A, Foss F, Totonchy M. DUSP22-IRF4 rearrangement in AIDS-associated ALKnegative anaplastic large cell lymphoma. BMJ Case Rep. 2019 Sep 30;12(9):e230641. doi: 10.1136/bcr-2019-230641. PMID: 31570354; PMCID: PMC6768350.
3. Gong J, Delioukina ML, Hendifar AE. A Rare Case of Primary Gastric HIV-Associated Peripheral T-Cell Lymphoma: Relapsed Disease Treated With Pemetrexed. World J Oncol. 2013 Oct;4(4-5):217-220. doi: 10.4021/wjon708w. Epub 2013 Sep 27. PMID: 29147360; PMCID: PMC5649932.
4. Castillo J, Perez K, Milani C, Dezube BJ, Pantanowitz L. Peripheral T-cell lymphomas in HIV-infected individuals: a comprehensive review. J HIV Ther. 2009;14(2):34–40.
5. Biggar RJ, Engels EA, Frisch M, Goedert JJ. Risk of Tcell lymphomas in per-sons with AIDS. J Acquir Immune Defic Syndr 2001;26:371–376.
6. Castillo JJ, Beltran BE, Bibas M, Bower M, Collins JA, Cwynarski K, Diez-Martin JL, Hernandez-Ilizaliturri F, Horwitz SM, Montoto S, Pantanowitz L, Ribera JM, Vose JM. Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study. Am J Hematol. 2011 Mar;86(3):256-61. doi: 10.1002/ajh.21947. Epub 2011 Feb 15. Erratum in: Am J Hematol. 2011 Aug;86(8):721. PMID: 21328430.
7. Arzoo KK, Bu X, Espina BM, et al. T-cell lymphoma in HIV-infected patients. JAcquir Immune Defic Syndr 2004;36:1020–1027.
8. Brimo F, Michel RP, Khetani K, Auger M. Primary effusion lymphoma: Aseries of 4 cases and review of the literature with emphasis on cytomor-phologic and immunocytochemical differential diagnosis. Cancer 2007;111:224–233.
9. Collins JA, Hernandez AV, Hidalgo JA, et al. High proportion of T-cell systemic non-Hodgkin lymphoma in HIVinfected patients in Lima, Peru. J AcquirImmune Defic Syndr 2005;40:558–564.
10. Nava VE, Cohen P, Kalan M, Ozdemirli M. HIV-associated anaplastic largecell lymphoma: A report of three cases. Aids 2008;22:1892–1894.
11. Yang Z, Gong D, Huang F, Sun Y, Hu Q. Epidemiological Characteristics and the Development of Prognostic Nomograms of Patients With HIV-Associated Cutaneous T-Cell Lymphoma. Front Oncol. 2022 Mar 15;12:847710.
Review
For citations:
Shelomov A.S., Bejanyan Ya.G., Stepanova E.V., Burdaeva S.S. A clinical case of peripheral T-cell lymphoma in a patient with HIV infection. Journal Infectology. 2025;17(4):159-163. (In Russ.) https://doi.org/10.22625/2072-6732-2025-17-4-159-163
JATS XML



















































.png)
.png)

